RoadToPosterBoy
Sculpted, not born. | 5´10 HMTN
- Joined
- Oct 30, 2025
- Posts
- 225
- Reputation
- 140
Hey everyone,
I'm turning 18 soon and scheduling an X-ray to check if my epiphyseal plates (growth plates) are still open or partially fused. I've done quite a bit of research on height growth mechanics, growth hormone pathways, and endocrine factors, but I want to get some community input on optimizing a potential run before making any definitive decisions.
My situation & questions:
2. HGH Protocol: If the plates are confirmed to be open, my primary consideration is running an HGH protocol. What dosing range and administration timing (e.g., pre-bed vs. split dosing) are generally considered optimal for maximum vertical growth without prematurely triggering plate closure?
3. Ancillaries & Synergistic Compounds:
Aromatase Inhibitors (Als): Since estrogen
(E2) is the primary driver of epiphyseal fusion, does running a low-dose Al (like Anastrozole or Aromasin) make sense to delay closure, or is there a risk of crushing E2 too far and hurting
overall growth/health?
4. Bloodwork & Health Markers: Beyond IGF-1 and Estradiol, which specific baseline markers (fasting insulin, HAlc, thyroid panel, lipids) should I prioritize before and during a cycle?
Appreciate any insights, experience, or critiques on the protocol!
I'm turning 18 soon and scheduling an X-ray to check if my epiphyseal plates (growth plates) are still open or partially fused. I've done quite a bit of research on height growth mechanics, growth hormone pathways, and endocrine factors, but I want to get some community input on optimizing a potential run before making any definitive decisions.
My situation & questions:
- Growth Plate Assessment: Given that I'm almost 18, I know the window is closing fast.
What specific features on the hand/wrist X-ray should I pay closest attention to regarding partial closure?
2. HGH Protocol: If the plates are confirmed to be open, my primary consideration is running an HGH protocol. What dosing range and administration timing (e.g., pre-bed vs. split dosing) are generally considered optimal for maximum vertical growth without prematurely triggering plate closure?
3. Ancillaries & Synergistic Compounds:
Aromatase Inhibitors (Als): Since estrogen
(E2) is the primary driver of epiphyseal fusion, does running a low-dose Al (like Anastrozole or Aromasin) make sense to delay closure, or is there a risk of crushing E2 too far and hurting
overall growth/health?
- What other supportive compounds, thyroid support (T3/T4), or insulin management strategies (e.g., Metformin/Berberine) are essential when running HGH for height?
4. Bloodwork & Health Markers: Beyond IGF-1 and Estradiol, which specific baseline markers (fasting insulin, HAlc, thyroid panel, lipids) should I prioritize before and during a cycle?
Appreciate any insights, experience, or critiques on the protocol!

could I still dm you for help or smth jfl